LogicBio Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.11.22	LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates (PR Newswire)
31.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC (PR Newswire)
19.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK (PR Newswire)
11.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOTZ, LOGC, OIIM, JVA (PR Newswire)
04.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, POSH, SSNT (PR Newswire)
03.10.22	LogicBio To Be Bought By Alexion, AstraZeneca Rare Disease (RTTNews)
03.10.22	Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine (PR Newswire)
21.09.22	LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE (PR Newswire)
15.08.22	LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
17.05.22	LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment Conference (PR Newswire)
16.05.22	LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business Updates (PR Newswire)
11.05.22	LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting (PR Newswire)
09.05.22	LogicBio Says FDA Lifts Clinical Hold On LB-001 IND (RTTNews)
09.05.22	LogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia (PR Newswire)
23.03.22	LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference (PR Newswire)
08.03.22	LogicBio Therapeutics to Present at Barclays Global Healthcare Conference (PR Newswire)
04.03.22	LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates (PR Newswire)
02.02.22	LogicBio Therapeutics' Phase 1/2 SUNRISE Trial Of LB-001 Placed On Clinical Hold (RTTNews)
02.02.22	LogicBio Therapeutics Provides Update on LB-001 Clinical Development Program (PR Newswire)
04.01.22	LogicBio Therapeutics to Present at the H.C. Wainwright Bioconnect Conference (PR Newswire)
22.12.21	LogicBio Therapeutics Provides Business Updates (PR Newswire)
15.11.21	LogicBio Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones (PR Newswire)
11.11.21	LogicBio Therapeutics to Participate in Upcoming Investor Conferences (PR Newswire)
21.10.21	LogicBio Therapeutics Announces Successful Repopulation of Diseased Livers in Mice with Healthy Corrected Hepatocytes in Two New Indications Using GeneRide™ Genome Editing Technology (PR Newswire)
18.10.21	LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children (PR Newswire)
12.10.21	LogicBio Therapeutics to Present New GeneRide™ Data at the European Society of Gene and Cell Therapy Virtual Congress 2021 (PR Newswire)
24.09.21	LogicBio Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference (PR Newswire)
10.09.21	LogicBio Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
09.08.21	LogicBio Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones (PR Newswire)
08.07.21	LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021 (PR Newswire)
27.04.21	LogicBio Collaborates With CANbridge Pharma; Grants Option To License LB-001 In Greater China (RTTNews)
11.02.20	ACST Plunges On Data Delay, MREO On Watch, AQST Faces FDA In Sep. (RTTNews)
30.08.19	6 Top Gainers In Healthcare Sector (LOGC, CDTX, QDEL…) (RTTNews)
06.08.19	5 Top Losers In Healthcare Sector (GLYC, LOGC, KZR…) (RTTNews)
13.06.19	5 Top Gainers In Healthcare Sector (SYBX, HEB, TOCA...) (RTTNews)
17.04.19	6 Top Gainers In Healthcare Sector (RNN, LOGC, TCRR...) (RTTNews)
20.12.18	ADIL On The Job, ADRO Teams Up With LLY, So Long CIVI (RTTNews)
14.12.18	ALT Hits New Low, FPRX Down 26% This Month, VBIV Prices Stock Offering (RTTNews)
30.10.18	CASI Turning Heads, GEN On Watch, MRKR For The Long Haul (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	133.55	4.50 %	K V
Swiss Life Hldg	693.60	0.93 %	K V
Zurich Insur Gr	552.80	0.91 %	K V
Kuehne+Nagel Int	206.60	0.78 %	K V
Sonova Hldg	294.00	0.58 %	K V
Sika	228.20	-1.04 %	K V
Part Grp Hldg	1’264.50	-1.56 %	K V
Geberit	538.20	-1.61 %	K V
Alcon	75.22	-1.75 %	K V
Lonza Grp	532.80	-2.81 %	K V

Nachrichten zu LogicBio Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten